Articles tagged with Parkinsons Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A large cohort study found that chronic pesticide exposure is associated with an increased risk of Parkinson's disease, regardless of occupation or home use. The study suggested that exposure to specific pesticides may be the underlying cause of this increased risk.
A study of 143,325 participants found a strong association between pesticide exposure and Parkinson's disease, with a 70% higher incidence among those exposed. The association was strongest among individuals who used pesticides at home or in gardening, regardless of occupation or sex.
Researchers at Whitehead Institute identified a critical biological pathway responsible for Parkinson's symptoms and developed a treatment to repair it. Increasing levels of a transport protein restored normal neurological function in animal models, including fruit flies, worms, and rats with alpha-synuclein-induced Parkinson's symptoms.
Researchers have identified a key defect in ER-to-Golgi trafficking that contributes to alpha-synuclein toxicity, a hallmark of Parkinson's disease. Enhancing this pathway may suppress alpha-synuclein toxicity and protect dopamine-producing neurons.
Researchers identified minocycline's role in blocking poly(ADP-ribose) polymerase-1 (PARP-1), a protein linked to inflammation and cell death. The study suggests minocycline's potential as a treatment for neurodegenerative diseases, but raises concerns about its effects on cancer risk and gender differences.
A study found that REM sleep behavior disorder is a precursor to neurodegenerative diseases such as Parkinson's disease and dementia with Lewy bodies. Patients with RBD are at increased risk for developing these conditions, which can lead to serious consequences like brain hemorrhages and death.
A new study by Mayo Clinic researchers found that pesticide use increases the risk of Parkinson's disease in men, with a higher likelihood of exposure compared to women. The study matched individuals with Parkinson's disease to those without, assessing exposure via farming occupation or hobbies.
Researchers found that individuals with a single copy of the parkin gene mutation exhibit an average age of onset around 43 years old. This discovery challenges current understanding and highlights the need for further investigation into the role of partial parkin gene expression in Parkinson's disease.
Researchers found that individuals with one mutated parkin gene and one normal gene (heterozygotes) developed Parkinson's disease 11.7 years earlier than those with no mutations, indicating a stronger genetic effect than previously recognized.
Researchers discovered that an aspirin-like drug called sodium para-aminosalicylic acid dramatically reduces symptoms of manganese intoxication. The treatment has been shown to reverse Parkinson-type symptoms even 17 years after initial exposure.
A study identifies Protein Disulphide Isomerase as a marker for neurodegenerative diseases, while also showing its potential as a therapeutic target. The research reveals that NO attacks PDI via S-nitrosylation, altering its function and leading to nerve cell injury.
Researchers found a connection between DJ-1 protein and neurodegeneration in Parkinson's disease, suggesting that environmental toxins may trigger oxidative stress. The study suggests that understanding the role of DJ-1 may lead to the development of new treatments for Parkinson's disease and potentially other neurological disorders.
UB researchers have discovered an agent, L-AP4, that activates group III metabotropic glutamate receptors and reverses damage caused by rotenone. The findings could lead to a new treatment for Parkinson's disease.
Research identifies three estrogen-related gene variants associated with an increased risk of Parkinson's disease in women. The study found that these genetic variations affect 10-20% of the female population and could be used to predict disease risk using a simple blood test.
The new guidelines provide recommendations for early diagnosis, effective therapies, and screening for depression and psychosis. Regular exercise and therapy can also help manage movement difficulties, improving overall quality of life for those with Parkinson disease.
Researchers at MIT have discovered a compound called B2 that promotes the formation of large protein inclusions, which may help stop Huntington's disease progression. The compound also shows promise for treating Parkinson's disease, another neurodegenerative disorder caused by misfolded proteins.
Researchers found that male-specific gene SRY is required for normal brain function of dopamine-secreting neurons. This may help explain the higher incidence of Parkinson's disease in males, which exhibits a 3:2 ratio with females.
A male-specific gene, SRY, has been found to be linked to the control of physical movement and may contribute to the higher incidence of Parkinson's disease in men. The protein, which determines male gender, was discovered in British scientists in 1990.
Researchers found that the SRY gene plays a crucial role in regulating dopamine-producing brain cells, which malfunction in Parkinson's disease. The study suggests that men are more susceptible to the disease due to lower levels of this gene, while women may have an alternative protective mechanism involving estrogens.
Two genes, Lmx1a and Msx1, play a critical role in forming cerebral dopamine cells. This discovery can be used to control the formation of dopamine-producing cells from stem cells in a highly effective manner, representing an important step towards a stem-cell-based treatment for Parkinson's Disease.
A study led by scientists at Einstein and Beth Israel found a significant link between the G2019S LRRK2 gene mutation and Parkinson's disease in Ashkenazi Jewish patients. The mutation was detected in 18.3% of patients, highlighting the importance of genetic counseling for early detection and diagnosis.
A study found nearly 78% of test subjects had neurofibrillary tangles in the substantia nigra, linked to increased gait impairment. The relationship was independent of dementia status and only affected gait.
Researchers at Northwestern University have developed a gene therapy that turns off the alpha-synuclein protein, a key player in Parkinson's disease. The therapy uses RNA interference to selectively disable the gene, leaving other genes unaffected, and has shown promising results in rat models.
A major gene therapy advance for treating Parkinson's disease has been funded by the Fox Foundation grant, with RheoGene Inc. developing a technology to manage gene expression. The therapy uses a patented small-molecule mediator to turn genes on or off, offering a potential solution to replacing lost dopamine in the brain.
Scientists have identified 570 genes associated with Parkinson's disease, which could lead to the development of new treatments. The study analyzed brains from 23 patients and found that limiting the activity of these genes may help control or even stop the progression of the disease.
Scientists have engineered human brain progenitor cells to produce a growth factor that has shown clinical promise for treating Parkinson's disease. The cells were transplanted into rats and monkeys, delivering the drug where it is needed, promoting nerve fiber growth and improving survival of defective cells.
Researchers evaluated the effect of unilateral implantation of human RPE cells attached to gelatin microcarriers in six patients with advanced Parkinson disease. The study showed a 48% average improvement in motor symptoms at 12 months, sustained through 24 months, with no off-state dyskinesias observed.
David Eidelberg receives the prestigious Fred Springer Award for his work on mapping brain pathways and developing new diagnostic techniques. The award recognizes his pioneering efforts in viewing the brain at work, early diagnosis, and predicting treatment responses.
A new guidance system automates electrode placement in DBS surgery, reducing operating times by up to 80% and improving patient outcomes. The system uses a 3D brain atlas to predict target locations, allowing neurosurgeons to hit the mark on their first try.
Researchers found highest increase in Parkinson's risk among highly educated individuals (9+ years of education), while physicians had the greatest increased risk compared to the general population. The study suggests that physical activity may protect against Parkinson's disease, but further studies are needed to confirm these findings.
Researchers at Johns Hopkins have discovered a protein called LRRK2 that could be the best new target in the fight against Parkinson's disease. The study found that LRRK2 is involved in controlling other proteins' activities and may play a role in the death of brain cells that produce dopamine.
Researchers at OHSU found that mice consuming fewer calories experienced a boost in essential neurochemical glutamate, which reversed a Parkinson's-induced drop. The study suggests dietary restriction may be beneficial in early-stage Parkinson's disease.
Researchers discovered that alpha-synuclein, a disease-causing protein, has a protective effect against nerve damage in Parkinson's disease. This finding was made by studying mutant mice that were bred to have different levels of alpha-synuclein and cysteine-string-protein-alpha, a co-chaperone.
A recent study published in the Journal of the American Geriatrics Society found that older men with Parkinson's disease have significantly lower bone density at the spine and hip, increasing their risk for bone fractures. The study also revealed a nearly three times greater risk of multiple future falls among those with PD.
A woman's fear of falling led to a psychological disorder affecting her ability to walk, but treatment helped improve her bearing and mobility. After discovering the condition was not physically related, she began walking again after six months of physical therapy and reduced medication.
Researchers at the University of Wisconsin-Madison have developed a new lithium battery technology that can make batteries smaller, last longer, and accept external charging without surgery. This breakthrough technology uses organosilicon compounds to improve battery lifespan, enabling implantable devices such as pacemakers and microst...
The Phase I trial demonstrated the treatment's safety and efficacy in advanced Parkinson's disease, with statistically significant improvements in motor function and activities of daily living. The gene therapy approach offers a simpler alternative to deep brain stimulation, avoiding devices and requiring local anesthesia.
OHSU neurologists offer reliable strategies for diagnosing and managing Parkinson's disease. The article highlights the importance of non-pharmacological therapies such as exercise, nutrition, and emotional health in addition to pharmacological care.
The research provides a comprehensive whole genome map of genetic variability in Parkinson's disease, highlighting 12 potential 'susceptibility' genes. The findings may lead to new insights into the causes of Parkinson's disease and inform future research efforts.
Researchers created an animal model of Parkinson's disease using fruit flies with deleted DJ-1 genes, finding increased sensitivity to oxidative damage from common agricultural agents. The study suggests that DJ-1 plays a critical role in protecting dopaminergic neurons from oxidative stress.
Researchers have found that amphetamine-related drugs, such as MDMA, can effectively alleviate symptoms of Parkinson's disease in a mouse model. By eliminating dopamine recycling and production, these drugs bypass the usual limitations of L-DOPA treatment, offering new hope for patients with the debilitating condition.
Researchers discover that amphetamines can alter movement independently of dopamine, opening up new directions in the search for anti-Parkinsonian drugs. The findings suggest that drugs with similar chemical attributes might offer useful alternatives to current therapies.
A study by Mayo Clinic researchers found a rare link between dopamine agonist drugs and pathological gambling in Parkinson's patients. The behavior can be reversed by stopping the medication, but it affects only a small number of patients.
Researchers report a link between dopamine agonist therapy and pathological gambling in Parkinson's disease patients. Treatment discontinuation resolves symptoms, suggesting dopamine D3 receptors may be responsible for the behavior.
Researchers have discovered that an experimental drug can reverse the loss of nerve fibres in Parkinson's Disease. The study found that dopamine-containing nerve fibres had sprouted back in the brain, leading to improved motor function and sustained benefits even after treatment cessation.
Researchers at UT Southwestern Medical Center discovered a vicious cycle of protein formation involving alpha-synuclein, leading to fibril formation and further protein clumping. The study suggests that inhibiting the malicious form of an enzyme could potentially lead to new treatment avenues for Parkinson's disease.
Scientists at UCSD and Elan Pharmaceuticals have successfully vaccinated mice with a combination of human alpha-synuclein protein and adjuvant, reducing abnormal alpha-synuclein accumulation and promoting nerve cell survival.
Researchers made significant findings on the risk factors for Parkinson's disease, including active duty military service and ibuprofen use. Additionally, donepezil showed promise in slowing cognitive decline in Alzheimer's patients, while essential tremor was linked to increased dementia risk.
A recent study published by the American Academy of Neurology suggests that long-term use of ibuprofen may lower the risk of developing Parkinson's disease. The research found a 35% lower risk among ibuprofen users compared to non-users, with risks decreasing depending on weekly dosage.
A study at Mayo Clinic found an association between anxious and pessimistic personality types and the future development of Parkinson's disease. Individuals with these personality traits have a higher risk of developing the disease, but the exact reason for this link remains unclear.
A study published by Mayo Clinic researchers found that removing the ovaries elevates the risk of Parkinson's disease and parkinsonism in women. The study, which analyzed data from over 2,500 women, suggested that a reduction in estrogen levels after ovary removal may contribute to this increased risk.
Rufinamide shows promise in reducing seizures for patients with treatment-resistant Lennox-Gastaut epilepsy. A new gene mutation in Charcot-Marie-Tooth disease and a common mutation in Parkinson's disease were also identified, offering potential new avenues for research.
A study found that deep brain stimulation with STN and GPi targets improves off-medication motor scores and levodopa-induced dyskinesia for at least one year. STN stimulation may be better for younger patients with prominent bradykinesia, while GPi stimulation is better suited for dose-limiting dyskinesia.
Researchers have created a mouse model of multiple system atrophy, showing symptoms similar to human MSA, including protein accumulation in oligodendrocytes and progressive motor skill problems. The study points to potential new treatment targets for brain diseases and opens up possibilities for testing therapies.
A study published in The Lancet found that rasagiline significantly reduces disability and motor fluctuations in patients with advanced Parkinson's disease, improving their motor function. Rasagiline was well-tolerated and convenient to administer, making it a promising treatment option for Parkinson's patients.
A recent study found that the LRRK2 gene mutation is associated with Parkinson's disease in several families, indicating a genetic component of the disease. The mutation was identified in 22 out of 42 family members who carried the G2019S mutation, and all shared a common ancestral pattern.
Men who were most physically active at start of study cut their risk by 50 percent, while strenuous activity in early adult life reduced risk by 60 percent. Physical activity was also linked to lower risk in women, although this relationship was not statistically significant.
A study published in NeuroToxicology reveals that polychlorinated biphenyls (PCBs) and low levels of maneb, a fungicide, can disrupt dopamine neurons and oxidative stress responses in the brain. This research aims to better understand Parkinson's disease and develop therapies to prevent or slow its progression.
Scientists prevented brain damage by producing therapeutic levels of GDNF, a protein that helps nourish brain cells, in small monkeys. The gene therapy approach aims to halt Parkinson's disease at its onset and treat devastating side effects.
Researchers at UCL discovered a new method to improve Transcranial Magnetic Stimulation (TMS) that can produce effects on the brain for more than an hour. By adjusting stimulation patterns, they achieved rapid and consistent changes in the motor cortex area, outlasting conventional TMS.